Skip to main content

Vistagen Therapeutics, Inc.

VTGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001411685

No open-market purchases or sales by Vistagen Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $2.54M in total; no superinvestor holds it.

13F holders, Q4 2024

Institutional positions in Vistagen Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
54
+7 vs. Q3 2024
Shares held
15.5M
+260.1K (+1.7%) vs. Q3 2024
Total value
$44.9M
−$422.3K (−0.9%) vs. Q3 2024
New holders
15
19 more added
Sold out
8
10 more reduced

Compare with Q3 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VTGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2024: 54 institutions
Q1 2021: 74 institutionsQ2 2021: 101 institutionsQ3 2021: 105 institutionsQ4 2021: 106 institutionsQ1 2022: 116 institutionsQ2 2022: 112 institutionsQ3 2022: 93 institutionsQ4 2022: 86 institutionsQ1 2023: 83 institutionsQ2 2023: 33 institutionsQ3 2023: 34 institutionsQ4 2023: 46 institutionsQ1 2024: 42 institutionsQ2 2024: 43 institutionsQ3 2024: 47 institutionsQ4 2024: 54 institutionsQ1 2025: 48 institutionsQ2 2025: 51 institutionsQ3 2025: 58 institutionsQ4 2025: 55 institutionsQ1 2026: 56 institutionsQ2 2026: 48 institutions
Value heldQ4 2024: $44.9M
Q1 2021: $225.2MQ2 2021: $389.0MQ3 2021: $360.2MQ4 2021: $269.2MQ1 2022: $167.8MQ2 2022: $122.1MQ3 2022: $9.13MQ4 2022: $4.15MQ1 2023: $4.79MQ2 2023: $1.82MQ3 2023: $15.7MQ4 2023: $90.0MQ1 2024: $90.8MQ2 2024: $56.3MQ3 2024: $45.3MQ4 2024: $44.9MQ1 2025: $39.0MQ2 2025: $30.3MQ3 2025: $81.8MQ4 2025: $8.84MQ1 2026: $8.12MQ2 2026: $2.54M
Institutions holding VTGN and their total value by quarter
QuarterHoldersValue
Q2 202648$2.54M
Q1 202656$8.12M
Q4 202555$8.84M
Q3 202558$81.8M
Q2 202551$30.3M
Q1 202548$39.0M
Q4 202454$44.9M
Q3 202447$45.3M
Q2 202443$56.3M
Q1 202442$90.8M
Q4 202346$90.0M
Q3 202334$15.7M
Q2 202333$1.82M
Q1 202383$4.79M
Q4 202286$4.15M
Q3 202293$9.13M
Q2 2022112$122.1M
Q1 2022116$167.8M
Q4 2021106$269.2M
Q3 2021105$360.2M
Q2 2021101$389.0M
Q1 202174$225.2M

Institutions, Q4 2024

Shares, value and share of portfolio for each institution holding Vistagen Therapeutics, Inc.; share changes are against Q3 2024.

Institutions holding VTGN in Q4 2024
InstitutionSharesValue% of portfolioChange in sharesAction
TCG Crossover Management, LLC2,676,580$7.90M0.77%00.0%Unchanged
Vanguard Group Inc2,020,351$5.96M0.00%+227,185+12.7%Added
StemPoint Capital LP2,328,492$5.95M1.49%+481,700+26.1%Added
Nantahala Capital Management, LLC1,981,980$5.85M0.41%+464,284+30.6%Added
Commodore Capital LP1,575,000$4.65M0.34%00.0%Unchanged
Sphera Funds Management Ltd.808,550$2.39M0.44%00.0%Unchanged
JPMorgan Chase & Co772,244$2.28M0.00%+772,228+4,826,425.0%Added
Diadema Partners LP442,520$1.31M1.47%+442,520New
BlackRock, Inc.411,553$1.21M0.00%−576−0.1%Reduced
Geode Capital Management, LLC256,926$758.3K0.00%−1,598−0.6%Reduced
Almitas Capital LLC254,655$751.2K0.16%+254,655New
Goldman Sachs Group Inc194,533$573.9K0.00%+18,272+10.4%Added
BML Capital Management, LLC150,000$442.5K0.27%00.0%Unchanged
Two Sigma Investments, LP137,334$405.1K0.00%+75,792+123.2%Added
UBS Group AG132,314$390.3K0.00%+122,193+1,207.3%Added
ADAR1 Capital Management, LLC121,461$358.3K0.07%−41,617−25.5%Reduced
Persistent Asset Partners Ltd121,651$351.6K0.30%+121,651New
Squarepoint Ops LLC107,744$317.8K0.00%+80,169+290.7%Added
AdvisorShares Investments LLC99,810$294.4K0.06%+32,030+47.3%Added
Blair William & Co98,466$290.5K0.00%+10,000+11.3%Added
Group One Trading, L.P.97,727$288.3K0.01%+97,727New
State Street Corp96,858$285.7K0.00%+8,150+9.2%Added
Susquehanna International Group, LLP95,906$282.9K0.00%+43,812+84.1%Added
Renaissance Technologies LLC83,700$246.9K0.00%−106,900−56.1%Reduced
Ikarian Capital, LLC77,616$229.0K0.07%+77,616New
Northern Trust Corp45,211$133.4K0.00%−4,220−8.5%Reduced
Landscape Capital Management, L.L.C.41,804$123.3K0.01%+41,804New
Millennium Management LLC38,732$114.3K0.00%+13,395+52.9%Added
American Century Companies Inc30,002$88.5K0.00%−195−0.6%Reduced
Prosperity Wealth Management, Inc.29,250$86.3K0.04%+29,250New
Charles Schwab Investment Management Inc23,302$68.7K0.00%00.0%Unchanged
Boothbay Fund Management, LLC22,415$66.1K0.00%+22,415New
Bank of America Corp21,141$62.4K0.00%+19,331+1,068.0%Added
HighTower Advisors, LLC20,828$61.4K0.00%00.0%Unchanged
Kestra Advisory Services, LLC20,116$59.3K0.00%+83+0.4%Added
Man Group plc18,338$54.1K0.00%+18,338New
Morgan Stanley17,092$50.4K0.00%+11,773+221.3%Added
Two Sigma Advisers, LP12,032$35.5K0.00%+12,032New
Advisor Group Holdings, Inc.11,430$33.7K0.00%+1,204+11.8%Added
R Squared Ltd8,610$25.4K0.02%+8,610New
Caption Management, LLC4,460$13.2K0.00%00.0%Unchanged
CWM, LLC3,416$10.0K0.00%+1,000+41.4%Added
Simplex Trading, LLC2,593$7.00K0.00%−20,407−88.7%Reduced
Royal Bank of Canada1,859$5.00K0.00%−2,642−58.7%Reduced
BFSG, LLC1,000$2.95K0.00%00.0%Unchanged
Performa Ltd (US), LLC1,000$2.95K0.00%+1,000New
MAI Capital Management609$1.80K0.00%+609New
BNP Paribas Arbitrage, SA473$1.40K0.00%+473New
SBI Securities Co., Ltd.286$8440.00%+286New
Jones Financial Companies LLLP280$8260.00%+200+250.0%Added
Tower Research Capital LLC (TRC)223$6580.00%−2,036−90.1%Reduced
SJS Investment Consulting Inc.100$2950.00%00.0%Unchanged
Fairman Group, LLC29$860.00%00.0%Unchanged
Citigroup Inc3$90.00%−1,226−99.8%Reduced
BVF Inc0$00.00%−2,000,000−100.0%Sold out
Great Point Partners LLC0$00.00%−674,075−100.0%Sold out
Citadel Advisors LLC0$00.00%−321,885−100.0%Sold out
Valence8 US LP0$00.00%−34,376−100.0%Sold out
Virtu Financial LLC0$00.00%−20,210−100.0%Sold out
Jane Street Group, LLC0$00.00%−19,659−100.0%Sold out
Farther Finance Advisors, LLC0$00.00%−81−100.0%Sold out
FMR LLC0$00.00%−25−100.0%Sold out